Although the primary pro-fibrogenic signaling pathways, such as TGFβ/Smad signaling, Wnt/β-catenin, oxidative stress or inflammation, are relatively well recognized, the effective therapies against renal fibrosis-associated kidney pathogenesis are still lacking3. This evidence concerns the gene TGFB1 and renal fibrosis.